Continued Emphasis on the Brain Disease Model: Despite its limitations, the brain disease model continues to dominate largely because it supports the development and funding of medical treatments and pharmaceutical interventions, which are concrete, scalable, and economically beneficial for the medical and pharmaceutical industries. Additionally, this model has played a significant role in shaping public policies and research agendas. #Addiction #Recovery
Timothy Harrington’s Post
More Relevant Posts
-
Clients often inquire about Medicare coverage for experimental procedures, particularly for conditions like cancer. Here’s some essential information: For unique medical conditions, clinical trials offer new, unapproved treatments. Medicare typically does not cover these experimental procedures. However, the costs are often covered by the pharmaceutical company or the entity developing the therapy. It’s crucial to stay informed and understand all your options. #Medicare #Employeebenefits #Medicarecoverage #HRInnovation #HRChallenges #HR #DoctorsChoiceusa #Healthcare
How To Understanding Medicare Coverage for Experimental Procedures and Clinical Trials
To view or add a comment, sign in
-
Our research initiative aimed to understand the current diagnostic tests, pharmaceutical interventions, and treatment modalities for Chronic Kidney Disease. Engaging Nephrologists, Urologists, and Laboratory Directors, we gathered invaluable feedback. These insights highlighted gaps and unmet needs in CKD management, guiding future advancements. For research collaboration, email info@idr.co Visit www.idr.co to learn more about our projects. #healthcareresearch #CKD #medicalInnovation #mrx #marketresearch #competitiveintelligence #research #consulting #expertnetwork
To view or add a comment, sign in
-
FDA granted ATEV of Humacyte a special advanced-therapy designation on Monday. Find out more. https://lnkd.in/dN-r94hs #humacyte #investing #fda #regulator #stockmarketnews #unitedstates #biotech #healthcare #pharmaceuticals #businessnews #heartdisease #foodanddrugadministration
To view or add a comment, sign in
-
What is crucial for pharmaceutical companies to succeed with their clinical trials? Selected collection sites need to be audited in accordance to legal requierements. Anke Löffler is responsible for the qualification of apheresis units for autologous lymphocyte collections to ensure compliance with GMP regulations. She has already audited and supported more than 100 clinics and collection centers worldwide. Do you need support regarding the regulatory requirements that must be followed when dealing with human starting material? Get in touch with our Cellex experts. Your contact: businessdevelopment@cellex.me #startingmaterial #leukopaks #mobilizedleukopaks #wholeblood #bonemarrow #msc #celltherapy #genetherapy #research #healthydonormaterial #manufacturing #science #cdmo #ipsc
To view or add a comment, sign in
-
In today's pharmaceutical landscape, understanding medical imaging trends and innovations is crucial. With MHN's panel, access a wealth of expertise to elevate your research strategies and gain actionable insights. Pharmaceutical brands and insight agencies, are you seeking in-depth insights in radiology? Look no further than MHN's specialized panel of radiologists. Whether exploring new pharmaceutical developments, testing marketing strategies, or understanding healthcare professionals' evolving needs, our radiology panel offers the depth and breadth of knowledge you need. Partner with us to harness the power of radiology insights for informed decision-making in your pharmaceutical endeavors. Discover a world of possibilities with MHN! Reach out today to start your journey towards success. #RadiologyInsights #PharmaResearch #MedicalImaging 🩺💊🧠
To view or add a comment, sign in
-
The 4th Annual Psychedelic Therapeutics and Drug Development Conference has officially commenced! As a leader in helping bring psychedelic-assisted therapy to global health authorities for approval, we are hopeful that the discussions over the next 2 days bring forth new collaborations, ideas, and perspectives to a growing segment in the pharmaceutical industry. Don't miss our Regulatory Expert, Ritchie Patton’s session titled 'A Psychedelic Shift: Assessing the Potential for Nonmedical Use in a Changing Regulatory Landscape' on the first day at 4 PM! This session will dive deep into the challenges and nuances of evaluating nonmedical use potential for psychedelic drugs, highlighting the need for a refined regulatory approach. Expect insights into the FDA's requirements for abuse potential summaries and unique considerations for psychedelic therapeutics. For a deeper understanding of the evolving regulatory landscape and its implications, check out our latest blog: "Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of 'Nonmedical Use' on Labelling." 📖 Read more here: https://hubs.li/Q02yfjQQ0 #MDMA #Psychedelics #FDA #NewDrugApplication #PTSD #Neuroscience #DrugDevelopment #PsychedelicTherapeutics
Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling
To view or add a comment, sign in
-
In today's pharmaceutical landscape, understanding medical imaging trends and innovations is crucial. With MHN's panel, access a wealth of expertise to elevate your research strategies and gain actionable insights. Pharmaceutical brands and insight agencies, are you seeking in-depth insights in radiology? Look no further than MHN's specialized panel of radiologists. Whether exploring new pharmaceutical developments, testing marketing strategies, or understanding healthcare professionals' evolving needs, our radiology panel offers the depth and breadth of knowledge you need. Partner with us to harness the power of radiology insights for informed decision-making in your pharmaceutical endeavors. Discover a world of possibilities with MHN! Reach out today to start your journey towards success. #RadiologyInsights #PharmaResearch #MedicalImaging 🩺💊🧠
To view or add a comment, sign in
-
An excellent paper Carmen Moreno Redondo! Once again real-world data (RWD) is continuing to show promise in improving evidence generation and patient outcomes globally. This paper highlights what we continue to do at Cisiv Ltd, accelerating healthcare transformation by taking a patient-centric approach, which is essential for unlocking RWD's full potential. Add this to your reading list! #realworldevidence #realworlddata #patientoutcomes
We are delighted to share with you our new paper “Maximizing the Value of Real‐World Data and Real‐World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings” just published in Pharmaceutical Medicine Journal! Thank you to everyone involved for helping to make this achievement happen. To discover how RWD sources are empowering clinical practice and patient management in China, you can read the manuscript here: https://lnkd.in/eWVFksct
To view or add a comment, sign in
-
Thoughts on this? >> Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #biotech #productmarketing
Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug
endpts.com
To view or add a comment, sign in
-
In today's pharmaceutical landscape, understanding medical imaging trends and innovations is crucial. With MHN's panel, access a wealth of expertise to elevate your research strategies and gain actionable insights. Pharmaceutical brands and insight agencies, are you seeking in-depth insights in radiology? Look no further than MHN's specialized panel of radiologists. Whether exploring new pharmaceutical developments, testing marketing strategies, or understanding healthcare professionals' evolving needs, our radiology panel offers the depth and breadth of knowledge you need. Partner with us to harness the power of radiology insights for informed decision-making in your pharmaceutical endeavors. Discover a world of possibilities with MHN! Reach out today to start your journey towards success. #RadiologyInsights #PharmaResearch #MedicalImaging 🩺💊🧠
To view or add a comment, sign in